Navigation Links
Lignol provides financial and commercial update
Date:8/5/2014

LEC's current views with respect to future events and are subject to certain risks, uncertainties and assumptions including, without limitation, LEC's ability to immediately raise additional capital to fund operations and to support the capital requirements of its affiliates, the requirements of the potential effect of changes in government policy relating to the environment, and incentives for renewable fuels, the potential impact of changes in the prices of feedstock and the market price of liquid fuels including biodiesel, ethanol and renewable chemicals, the ability of LEC and its affiliates to generate future profits and to pay dividends, and to meet increasing regulatory requirements, the effect of changes in government policy relating to the environment, and incentives for renewable fuels, the ability to meet relevant local and international regulatory requirements.

Many factors could cause LEC's actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements or information, including among other things, financial market conditions which will impact LEC's ability to finance its operations and to meet future capital and investment requirements, the demand for the market price of liquid fuels including gasoline, biodiesel, ethanol, the market price and demand for renewable chemicals, risks relating to the protection of technology from infringement and those risk factors which are discussed elsewhere in documents that LEC files from time to time with securities and other regulatory authorities. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking statements or information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Except as required by law, LEC expressly d
'/>"/>

SOURCE Lignol Energy Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New Resource Provides Herb Industry With Sources of Quality Specifications
2. Amsterdam Molecular Therapeutics Provides Business Update for the Third Quarter 2011
3. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
4. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
5. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
6. Oxford Finance Provides $15 Million Senior Secured Credit Facility to Private Equity Backed Healthcare Services Company
7. Insmed Incorporated Provides Corporate Update
8. Van Andel Research Institute Study Provides New Details of Fundamental Cellular Process
9. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
10. Genomic Health Announces Year-End 2011 Financial Results, Provides 2012 Financial Outlook
11. CSL Behring Study Confirms Early Treatment with Berinert® Provides Faster Resolution of Acute Hereditary Angioedema Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... CA (PRWEB) February 26, 2015 The ... online demonstration to support life extension technologies and awareness. ... UTC, Universal Coordinated Time, on March 21st 2015, in ... world. , Eric Schulke, Founder of MILE, says, ... act with urgency. The Movement for Indefinite Life Extension ...
(Date:2/26/2015)... The Pittcon 2015 Exposition, which ... N. Morial Convention Center in New Orleans, Louisiana, ... 19, 2015) displaying products and services used by ... labs. The Exposition will offer the latest innovations ... analytical chemistry; drug discovery; nanotechnology; life sciences to ...
(Date:2/26/2015)... Feb. 26, 2015  Dyadic International, Inc. ("Dyadic") ... and proprietary technologies are used to develop, manufacture ... bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, ... results for year ending December 31, 2014 after ... will host a conference call that day at ...
(Date:2/26/2015)... , Feb. 26, 2015   Lexicon Pharmaceuticals, Inc. ... management will present at the Cowen 35 th Annual ... a.m. EST in Boston .  Lexicon management ... milestones. A webcast of the presentation will be ... version of the presentation will be available at www.lexpharma.com ...
Breaking Biology Technology:Indefinite Life Extension Activists Organize Online Demonstration 2Indefinite Life Extension Activists Organize Online Demonstration 3Pittcon 2015 Announces Exposition Highlights 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3Lexicon To Present At The Cowen 35th Annual Health Care Conference 2
... and CYPRESS, Calif., Nov. 15, 2011 Quest Diagnostics ... provider of diagnostic testing, information and services, today announced ... new Simplexa Cytomegalovirus (CMV) molecular test kit on the ... in Europe. The test is designed to enable hospital ...
... strategic effort to refocus and strengthen its organization, the ... planning to make adjustments in the direction, roles, responsibilities ... made by Denise Brown, FRA Interim Executive Director, who ... board of directors with four of the area,s most ...
... LA JOLLA, Calif., Nov. 15, 2011 DermTech, ... disease detection, announced  it will present results from ... can be used with a high-throughput, low-cost qRT-PCR ... recapitulated on a qRT-PCR system that successfully discriminated ...
Cached Biology Technology:Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe 2Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe 3Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 3
(Date:2/13/2015)... Feb. 13, 2015 ACT Genomics Co., ... aims to transform cancer genomic information into precision ... company has raised US$ 8 million in the its ... Taipei, Taiwan , ACT Genomics ... With the aim to implement next generation sequencing ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... cool lily look-alike. This new pinkish-purple ornamental flower, just patented ... but when left in the garden, it blooms all summer ... freeze in the fall., The new hybrid of the Inca ... professor, is a non-fragrant perennial that is set apart by ...
... Biomolecular Sciences (SBS) WHAT: Latest Findings and Research ... April 6-10, 2008 WHERE: SBS 14th ... More than 2,500 researchers and professionals in ... to attend the 14th Annual Conference & Exhibition of the ...
... of UPMCs Chief of the Division of Pediatric Neurosurgery ... the Childrens Brain Tumor Foundation for his pioneering work ... project, Molecular Makers of Outcome in Childhood Oligodendrogliomas, Dr. ... that he says has previously not been well studied ...
Cached Biology News:Cornell patents a pink lily look-alike that blooms all summer long 2Children's Hospital neurosurgeon receives grant 2